E.I.D.-Parry Q1 FY27: Results, Sugar Outlook, Capex, Future Plans & Management Commentary

BY ADMIN • FILED 19 Aug 2026, 3:05 PM

E.I.D.-Parry (India) Limited discussed its Q1 FY27 performance and business outlook during its earnings conference call held on August 13, 2026. Management highlighted the evolving global and Indian sugar environment, operational performance across sugar, biofuels, consumer products and nutraceuticals, as well as its focus on improving working capital, reducing debt and strengthening profitability. The company also outlined its plans for the CPG business, jaggery capacity expansion, PSRIPL closure and asset monetisation.

Important Points Discussed in the Meeting

Sugar prices: Management noted that domestic sugar prices have moved above ₹45–46 per kg, supported by tight inventories and steady demand, although some correction could occur once the new crushing season begins.
Sugar production strategy: With sugar prices currently attractive compared with ethanol prices, the company will evaluate the mix between sugar, ethanol and ENA based on margins while maintaining committed supplies to oil marketing companies.
Cane availability: Cane availability remains a concern in Tamil Nadu and Andhra Pradesh as farmers shift towards other crops. Management expects crushing in these regions could be flat or decline by around 5% in the current year.
Karnataka opportunity: Karnataka is expected to potentially compensate for lower cane availability in Tamil Nadu and Andhra Pradesh, provided crop yields remain strong.
CPG turnaround: The Consumer Products Group is being recalibrated toward higher-margin products. Management expects the business to reach quarterly breakeven in the next 4–5 quarters.
Jaggery expansion: A new jaggery plant in Karnataka is expected to be commissioned within around six months and will more than double existing jaggery capacity. Combined jaggery operations could generate close to ₹100 crore turnover.
Nutraceuticals growth: The Nutraceuticals business is seeing strong traction, particularly from the US-based Valensa business. Management expects the segment to potentially achieve 12–15% EBITDA margins once sufficient scale is achieved.
PSRIPL closure: Operations at PSRIPL have ceased, and all bank liabilities have been settled. The company is progressing with the SEZ exit process and plans to liquidate plant and machinery after obtaining the necessary approvals.
Debt reduction: Management is focused on improving working capital, reducing debt costs and monetising non-core assets. It expects to strengthen the balance sheet over the next 4–6 quarters.
Non-core asset monetisation: The company is evaluating the sale of non-operational land parcels, with management expecting some progress during FY27.
Long-term strategy: Over the next 3–4 years, the company aims to build consistent EBITDA generation from its core sugar and biofuels business, while growing the CPG and Nutraceuticals businesses as higher-value growth engines.

Results

E.I.D.-Parry reported a mixed operating performance in Q1 FY27. Sugar revenue increased to around ₹410 crore from ₹347 crore in the year-ago quarter, supported by higher sales volumes, while sugar crushing declined to 1.47 lakh tonnes from 2.12 lakh tonnes. Power segment revenue stood at ₹6.6 crore, while the Nutraceuticals business improved its consolidated turnover to ₹61 crore from ₹27 crore. However, the Consumer Products Group (CPG) revenue declined sharply to ₹94 crore from ₹188 crore as the company recalibrated its operating model, although management said the margin pool improved. The company also completed the settlement of PSRIPL’s bank liabilities, with ₹665 crore infused during the quarter, including ₹610 crore for settling obligations and ₹55 crore as a loan.

Capex

E.I.D.-Parry indicated that it does not have significant imminent capex plans, with management instead focused on improving capital efficiency and strengthening the balance sheet. The key near-term investment is a new jaggery plant in Karnataka, which is expected to be commissioned within around six months and will more than double the company’s existing jaggery capacity. Once both jaggery plants are operational, management expects the combined business to generate close to ₹100 crore in turnover. The company is also working on monetising non-core assets, including land parcels, with some asset-sale initiatives expected during FY27.

Future Plan

The company’s future strategy is focused on strengthening its core sugar and biofuels business while expanding higher-margin consumer products and nutraceuticals. Management aims to improve cost efficiency and restructuring in Tamil Nadu and other weaker-performing geographies, while leveraging Karnataka’s stronger operations. In CPG, the company plans to increase the contribution of value-added products such as jaggery and brown sugar, expand distribution and improve margins, with quarterly breakeven targeted over the next 4–5 quarters. The Nutraceuticals business is expected to continue its growth trajectory, particularly through the US-based Valensa business, while the company also plans to reduce debt through working-capital efficiencies and monetisation of non-performing/non-core assets.

Management Commentary

Management said its immediate priorities are working-capital efficiency, cost reduction, operational efficiency and balance-sheet strengthening. The company expects to improve its balance sheet over the next 4–6 quarters and reduce its reliance on short-term debt through better working-capital management and asset monetisation. Management remains cautiously optimistic about the sugar business, particularly Karnataka, but highlighted concerns over cane availability in Tamil Nadu and Andhra Pradesh. Strategically, E.I.D.-Parry aims to generate more consistent EBITDA from sugar and biofuels, build the CPG business through better margins and distribution, and scale the Nutraceuticals segment.

Disclaimer

This article is based on information discussed by the management of E.I.D.-Parry (India) Limited during its Q1 FY27 earnings conference call and is intended for informational and educational purposes only. It should not be considered investment advice, a recommendation to buy or sell any stock, or a guarantee of future performance. Investors should independently verify the information, review the company’s official filings and financial statements, and consult a qualified financial advisor before making any investment decisions.